Director Dealing

RNS Number : 2390K

Accrol Group Holdings PLC

20 December 2022

 

20 December 2022

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Accrol Group Holdings plc

("Accrol" or the "Company")

Director Dealing

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Gareth Jenkins, the Chief Executive Officer, for personal reasons, has sold 1,000,000 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 28.0 pence per Ordinary share.

Following this disposal, Gareth is interested in 4,422,929¹ Ordinary Shares representing 1.39% of the issued share capital of the Company.

¹ 3,741,346 of these Ordinary Shares are registered in the name of Gareth's wife Susan Jenkins.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Gareth Jenkins
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	213800MC56M5G69RJ226
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 each ISIN: GB00BZ6VT592
b)	Nature of the transaction	Sale of Ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.28 1,000,000
d)	Date of the transaction	19 December 2022
e)	Place of the transaction	London Stock Exchange, AIM

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton	Tel: [phone]
Dominic King	Tel: [phone]
Liberum Capital Limited (Joint Broker)	Tel: [phone]
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at £2.1bn at retail sales value.

The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today .

For more information, please visit www.accrol.co.uk

 

END

 

 

DSHFFFLIFALALIF